The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma. The U.S. Food and Drug Administration (FDA) has ...
Researchers have developed two simple, easy-to-deliver sessions to improve the wellbeing of staff in pediatric critical care (PCC) units in UK hospitals.
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...
WKBN Youngstown on MSN4d
Local doctor raises awareness for cervical cancer screening and preventionMore than 13,000 women are diagnosed with the cancer each year, but those rates are dropping thanks to advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback